Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Health In Tech, Inc. Class A ( (HIT) ) has shared an announcement.
On May 13, 2026, Health In Tech, Inc. held its first-quarter 2026 earnings call to review results for the period ended March 31, 2026, and to outline its strategic priorities for the year. Management reiterated that the company serves a massive, opaque self-funded stop-loss insurance market in which roughly 80% of large businesses, but only about 27% of medium and small businesses, have adopted self-funded plans, leaving significant runway for its AI-driven marketplace.
Executives framed 2026 as a deliberate investment year following profitable scaling in 2025, emphasizing plans to accelerate long-term revenue growth through expanded sales distribution, broader carrier participation and enhanced technology and AI capabilities. In March 2026, Health In Tech completed a PIPE transaction raising about $7 million in gross proceeds, which it characterized as opportunistic growth capital rather than a response to liquidity pressure, signaling a solid balance sheet and an intent to limit dilution while adding institutional shareholders.
The company plans to use the new capital to build out its sales and marketing organization, deepen engagement with the broker community and add new carrier partners, aiming to increase platform utilization and improve renewal competitiveness for employer clients. Management underscored that expanding the carrier network should provide brokers with more underwriting perspectives and options at renewal, enhancing employer stickiness and supporting stronger revenue growth as Health In Tech seeks to grow its penetration beyond the roughly 900 distribution partners currently using its platform.
The most recent analyst rating on (HIT) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Health In Tech, Inc. Class A stock, see the HIT Stock Forecast page.
Spark’s Take on HIT Stock
According to Spark, TipRanks’ AI Analyst, HIT is a Neutral.
The score is led by solid financial health (low leverage and improving cash flow) and upbeat earnings-call guidance pointing to materially higher growth in 2026. These positives are tempered by thin and less stable profitability (compressed margins/declining ROE), a neutral-to-mixed technical picture, and weak/unclear valuation signals due to a negative P/E and no dividend yield.
To see Spark’s full report on HIT stock, click here.
More about Health In Tech, Inc. Class A
Health In Tech, Inc. operates in the self-funded healthcare and stop-loss insurance market, providing an AI-powered technology platform that connects employers, insurance brokers and carriers. Its core marketplace, eDYIBS, aims to simplify and accelerate the design, underwriting and placement of self-funded health plans, targeting the largely underpenetrated medium and small business segment through a network of distribution partners and carrier relationships.
The company’s platform generates bindable, execution-ready quotes based on carrier-specific risk criteria, offering convenience, customization and faster time to quote for brokers and employers. Health In Tech’s business model scales primarily through broker distribution, and management is focused on expanding both its broker network and carrier participation to improve choice, pricing competitiveness and retention for employer groups.
Average Trading Volume: 297,243
Technical Sentiment Signal: Strong Sell
Current Market Cap: $86.76M
See more data about HIT stock on TipRanks’ Stock Analysis page.